JP2006515870A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515870A5 JP2006515870A5 JP2006500369A JP2006500369A JP2006515870A5 JP 2006515870 A5 JP2006515870 A5 JP 2006515870A5 JP 2006500369 A JP2006500369 A JP 2006500369A JP 2006500369 A JP2006500369 A JP 2006500369A JP 2006515870 A5 JP2006515870 A5 JP 2006515870A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- ophthalmic
- vaccine
- vaccine according
- neuropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43831003P | 2003-01-07 | 2003-01-07 | |
| US60/438,310 | 2003-01-07 | ||
| PCT/IL2004/000006 WO2004060265A2 (en) | 2003-01-07 | 2004-01-06 | Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006515870A JP2006515870A (ja) | 2006-06-08 |
| JP2006515870A5 true JP2006515870A5 (https=) | 2007-03-01 |
| JP5291878B2 JP5291878B2 (ja) | 2013-09-18 |
Family
ID=32713312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006500369A Expired - Fee Related JP5291878B2 (ja) | 2003-01-07 | 2004-01-06 | 治療的免疫のためのコポリマー１を含む点眼ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070248569A1 (https=) |
| EP (1) | EP1583506B1 (https=) |
| JP (1) | JP5291878B2 (https=) |
| CN (2) | CN102580069B (https=) |
| AT (1) | ATE548045T1 (https=) |
| AU (1) | AU2004203772B2 (https=) |
| CA (1) | CA2512735C (https=) |
| ES (1) | ES2386435T3 (https=) |
| IL (1) | IL169552A (https=) |
| MX (1) | MXPA05007329A (https=) |
| WO (1) | WO2004060265A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007264682B2 (en) * | 2006-06-28 | 2012-09-06 | Yeda Research & Development Co. Ltd | Method of treatment of age-related macular degeneration |
| WO2009040814A1 (en) | 2007-09-24 | 2009-04-02 | Hadasit Medical Research Services & Development Ltd | Use of copolymer 1 for treatment of muscular dystrophy |
| EP2326342B1 (en) | 2008-08-15 | 2021-10-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using interferon gamma to absorb fluid from the subretinal space |
| US11673914B2 (en) | 2009-11-10 | 2023-06-13 | Allegro Pharmaceuticals, LLC | Peptide therapies for reduction of macular thickening |
| MX346362B (es) | 2009-11-10 | 2017-03-15 | Allegro Pharmaceuticals Inc * | Composiciones y metodos para inhibir la adhesion celular o dirigir agentes de diagnostico o terapeuticos a sitios de enlace rgd. |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) * | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| CA2814500A1 (en) | 2010-10-11 | 2012-04-19 | Teva Pharmaceutical Industries Ltd | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| WO2012143924A1 (en) | 2011-04-21 | 2012-10-26 | Mapi Pharma Ltd. | Random pentapolymer for treatment of autoimmune diseases |
| HK1200274A1 (en) | 2011-10-10 | 2015-08-07 | Teva Pharmaceutical Industries Ltd. | Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate |
| WO2015038891A2 (en) * | 2013-09-13 | 2015-03-19 | The Penn State Research Foundation | Functional peptide analogs of pedf |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| CN109982712A (zh) | 2016-08-31 | 2019-07-05 | Mapi医药公司 | 包含醋酸格拉替雷的储库系统 |
| CN106491614A (zh) * | 2016-12-06 | 2017-03-15 | 郑州郑先医药科技有限公司 | 一种用于治疗脊髓损伤的西药组合及用途 |
| EP3570867A4 (en) * | 2017-01-19 | 2020-12-23 | Allegro Pharmaceuticals, LLC | THERAPEUTIC PEPTIDES AND NEUROPROTECTORS |
| CN110382052A (zh) | 2017-03-26 | 2019-10-25 | Mapi医药公司 | 用于治疗进展型形式的多发性硬化症的格拉替雷储库系统 |
| US11692029B2 (en) | 2018-03-05 | 2023-07-04 | The Schepens Eye Research Institute, Inc. | Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors |
| US20230181458A1 (en) * | 2020-04-30 | 2023-06-15 | Jeffrey E. Koziol | Micro dosing of viral vaccines |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE147633T1 (de) | 1988-10-27 | 1997-02-15 | Univ Minnesota | Immunhilfsmittel aus liposome enthaltend lymphokin il -2 |
| ZA93216B (en) | 1992-01-17 | 1993-08-18 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant. |
| US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
| IL113812A (en) | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| US6214791B1 (en) * | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| US6153182A (en) * | 1997-12-19 | 2000-11-28 | Uab Research Foundation | Lymphotactin as an adjuvant |
| EP1054880A1 (en) * | 1998-02-13 | 2000-11-29 | Autoimmune, Inc. | TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES |
| US6616925B1 (en) * | 1998-04-02 | 2003-09-09 | I.D.M. Immuno-Designed Molecules | Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| CA2361377C (en) * | 1999-02-05 | 2009-02-03 | Alk-Abello A/S | Novel mucosal delivery system |
| IL148247A0 (en) * | 1999-08-24 | 2002-09-12 | Teva Pharma | A vaccine composition and method of using the same |
| JP4328050B2 (ja) | 2000-01-20 | 2009-09-09 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | 神経保護療法のためのコポリマー１、関連ペプチド及びポリペプチドならびにそれらによって処理されたｔ細胞の使用 |
| EP1294390B1 (en) * | 2000-06-07 | 2006-01-04 | YEDA RESEARCH AND DEVELOPMENT CO., Ltd. | The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotection from glutamate toxicity |
| US7351686B2 (en) | 2001-12-06 | 2008-04-01 | Yeda Research And Development Co. Ltd. | Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
| WO2005030955A1 (ja) | 2003-09-29 | 2005-04-07 | Chugai Seiyaku Kabushiki Kaisha | Nk細胞に発現するタンパク質 |
| JP4501562B2 (ja) | 2004-07-09 | 2010-07-14 | 旭硝子株式会社 | 積層膜付き基材およびその製造方法 |
-
2004
- 2004-01-06 ES ES04700289T patent/ES2386435T3/es not_active Expired - Lifetime
- 2004-01-06 CA CA2512735A patent/CA2512735C/en not_active Expired - Fee Related
- 2004-01-06 MX MXPA05007329A patent/MXPA05007329A/es active IP Right Grant
- 2004-01-06 WO PCT/IL2004/000006 patent/WO2004060265A2/en not_active Ceased
- 2004-01-06 CN CN201110438909.1A patent/CN102580069B/zh not_active Expired - Fee Related
- 2004-01-06 US US10/541,492 patent/US20070248569A1/en not_active Abandoned
- 2004-01-06 JP JP2006500369A patent/JP5291878B2/ja not_active Expired - Fee Related
- 2004-01-06 EP EP04700289A patent/EP1583506B1/en not_active Expired - Lifetime
- 2004-01-06 AU AU2004203772A patent/AU2004203772B2/en not_active Ceased
- 2004-01-06 AT AT04700289T patent/ATE548045T1/de active
- 2004-01-06 CN CNA2004800062290A patent/CN1758922A/zh active Pending
-
2005
- 2005-07-06 IL IL169552A patent/IL169552A/en active IP Right Grant
-
2009
- 2009-05-07 US US12/437,167 patent/US8895501B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515870A5 (https=) | ||
| JP2005502616A5 (https=) | ||
| IL169552A (en) | Eye-drop vaccine containing copolymer 1 for systemic neuroprotection | |
| CA2451521A1 (en) | Use of poly-glu, tyr for neuroprotective therapy | |
| Rogers | Fractures and dislocations of the cervical spine: an end-result study | |
| Bakalash et al. | Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma | |
| CA2806942C (en) | Compounds for the treatment/prevention of ocular inflammatory diseases | |
| Schori et al. | T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system | |
| JP2004507460A5 (https=) | ||
| Kolahdouz-Isfahani et al. | Clear lens extraction with intraocular lens implantation for hyperopia | |
| JP2008521796A5 (https=) | ||
| Gedde et al. | Update on aqueous shunts | |
| JP2002535334A5 (https=) | ||
| DE112015000456T5 (de) | Verfahren und Zusammensetzungen zur Verwendung in der Behandlung inflammatorischer und Autoimmun-Krankheiten | |
| CN111760016A (zh) | 卡泊芬净在制备神经保护药物中的应用 | |
| RU2077293C1 (ru) | Способ лечения паралитического косоглазия | |
| Ascenzi et al. | The Telencephalon: Basal Ganglia | |
| Goodman et al. | Lamellar Keratectomy and Repeat Epikeratoplasty Following Failed Epikeratoplasty | |
| JP2002519394A5 (https=) | ||
| KUMAR et al. | PERIPHERAL IRIDECTOMY IN DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY: TO DO OR NOT TO DO | |
| HK40020736A (en) | Therapeutic and neuroprotective peptides | |
| Hamdi | The Copeland intraocular lens: five to ten years later | |
| Cai | Efficacy of Dexamethasone implant injection in the treatment of persistent diabetic macular edema | |
| WO2004060266A2 (en) | Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization | |
| Schwartz | Immune-based Therapies for Glaucoma |